Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$19.93 - $29.71 $265,069 - $395,143
-13,300 Reduced 8.87%
136,700 $2.83 Million
Q4 2023

Feb 14, 2024

BUY
$5.71 - $24.13 $856,500 - $3.62 Million
150,000 New
150,000 $3.47 Million
Q2 2022

Aug 15, 2022

SELL
$7.25 - $12.71 $362,500 - $635,500
-50,000 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$8.67 - $14.11 $2.75 Million - $4.47 Million
-316,700 Reduced 86.36%
50,000 $608,000
Q4 2021

Feb 11, 2022

BUY
$10.18 - $18.4 $1.78 Million - $3.22 Million
175,100 Added 91.39%
366,700 $4.49 Million
Q3 2021

Nov 12, 2021

BUY
$7.51 - $11.72 $1.44 Million - $2.25 Million
191,600 New
191,600 $2 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $242M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.